19972019
If you made any changes in Pure these will be visible here soon.

Research Output 1997 2019

Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs

Geersing, T. H., Franssen, E. J. F., Pilesi, F. & Crul, M., 30 Jan 2019, In : European Journal of Pharmaceutical Sciences.

Research output: Contribution to journalArticleAcademicpeer-review

Patient satisfaction with information on chemotherapy

Oosterhof, P., Sombroek, M. & Crul, M., 11 Apr 2019, In : European Journal of Oncology Pharmacy. p. 1

Research output: Contribution to journalArticleAcademicpeer-review

Stability of Furosemide 5 mg/mL in Polypropylene Syringes

van der Schaar, J. A. J., Grouls, R., Franssen, E. J. F. & Crul, M., 2019, In : International journal of pharmaceutical compounding. 23, 5, p. 414-417 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

The oncology pharmacist as part of the palliative treatment team

Crul, M. & Oosterhof, P., 1 Oct 2019, In : International Journal of Pharmacy Practice.

Research output: Contribution to journalArticleAcademicpeer-review

Voorschrijven en toedienen mtx bij buitenbaarmoederlijke zwangerschap: Bij extra uteriene graviditeit is methotrexaat vaker geïndiceerd

Verwiel, L. N., Crul, M., Lemmers, M. & Van Mello, N. M., 1 Nov 2019, In : Pharmaceutisch Weekblad. 154, 44, p. 10-13 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

2018

Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags

Breukels, O., van der Gronde, T., Simons-Sanders, K. & Crul, M., 2018, In : International journal of pharmaceutical compounding. 22, 4, p. 345-349

Research output: Contribution to journalArticleAcademicpeer-review

Carry-over of antineoplastic drug contamination in Dutch hospital pharmacies

Crul, M. & Simons-Sanders, K., 1 Oct 2018, In : Journal of Oncology Pharmacy Practice. 24, 7, p. 483-489 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Identificeren van micro-organismen bij aseptische handelingen

Boom, F. A., Veenbaas, T., Crul, M., Pavicic, M. J. A. M. P. & Ris, J. M., 2018, In : Pharmaceutisch Weekblad. 153, 46, p. 19-24

Research output: Contribution to journalArticleProfessional

Outcome effects of antiretroviral drug combinations in HIV-positive patients with chemotherapy for lymphoma: a retrospective analysis

Sombogaard, F., Franssen, E. J. F., Terpstra, W. E., Kerver, E. D., van den Berk, G. E. L. & Crul, M., 2018, In : International Journal of Clinical Pharmacy. 40, 5, p. 1402-1408

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

The effect of rapid infusion of cisplatin on nephrotoxicity in patients with lung carcinoma

Mense, E. S., Smit, A. A. J., Crul, M. & Franssen, E. J. F., 21 Dec 2018, In : Journal of Clinical Pharmacy and Therapeutics.

Research output: Contribution to journalArticleAcademicpeer-review

2017

A non-interventional retrospective cohort study of the interaction between methotrexate and proton pump inhibitors or aspirin

Boerrigter, E. & Crul, M., Sep 2017, In : Molecular Pharmaceutics. 75, 5, p. 344-348 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

Drug-drug interactions of cytostatics with regular medicines in lung cancer patients

Rompelman, F. M. V., Smit, A. A. J., Franssen, E. J. F. & Crul, M., Oct 2017, In : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 23, 7, p. 483-490 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review

Beets, G., Sebag-Montefiore, D., Andritsch, E., Arnold, D., Beishon, M., Crul, M., Dekker, J. W., Delgado-Bolton, R., Fléjou, J. F., Grisold, W., Henning, G., Laghi, A., Lovey, J., Negrouk, A., Pereira, P., Roca, P., Saarto, T., Seufferlein, T., Taylor, C., Ugolini, G. & 5 othersVelde, C. V. D., Herck, B. V., Yared, W., Costa, A. & Naredi, P., 1 Feb 2017, In : Critical Reviews in Oncology/Hematology. p. 81-93 13 p.

Research output: Contribution to journalArticleAcademicpeer-review

ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review

Andritsch, E., Beishon, M., Bielack, S., Bonvalot, S., Casali, P., Crul, M., Bolton, R. D., Donati, D. M., Douis, H., Haas, R., Hogendoorn, P., Kozhaeva, O., Lavender, V., Lovey, J., Negrouk, A., Pereira, P., Roca, P., de Lempdes, G. R., Saarto, T., van Berck, B. & 5 othersVassal, G., Wartenberg, M., Yared, W., Costa, A. & Naredi, P., 1 Feb 2017, In : Critical Reviews in Oncology/Hematology. p. 94-105 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

2013

cART op basis van proteaseremmers vermindert respons en geeft meer bijwerkingen bij chemotherapie tegen lymfomen dan cART op basis van niet-nucleoside reversetranscriptaseremmers

Sombogaard, F., Crul, M., Van Den Berk, G. E. L., Kerver, E. D. & Franssen, E. J. F., 7 Jun 2013, In : Pharmaceutisch Weekblad. 148, 23, p. 78-82 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

Clinical rule on safe methotrexate prescribing and dispensing in the Netherlands

Simons-Sanders, K. & Crul, M., 25 Oct 2013, In : European Journal of Oncology Pharmacy. 7, 1, p. 8-10 3 p.

Research output: Contribution to journalArticleAcademicpeer-review

Evaluation of the concurrent use of potassium-influencing drugs as risk factors for the development of hyperkalemia

Kuijvenhoven, M. A., Haak, E. A. F., Gombert-Handoko, K. B. & Crul, M., 1 Dec 2013, In : International Journal of Clinical Pharmacy. 35, 6, p. 1099-1104 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Persoonskwalificaties voor bereidende apothekersassistenten: Blijven werken aan bekwaamheid

Aleman, J. & Crul, M., 24 May 2013, In : Pharmaceutisch Weekblad. 148, 21, p. 28-31 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

2012

Anticholinergic toxicity after the ingestion of serotonergic 'magic mushrooms'

Aleman, J., Crul, M., van der Voort, P. H. J. & Franssen, E. J. F., 1 Jun 2012, In : Netherlands Journal of Critical Care. 16, 3, p. 93-96 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

Meetstrategie en instructie voor veegproeven: Inzicht in schoon werk en met oncolytica

Crul, M. & Duisenberg-Van Essenberg, M., 20 Apr 2012, In : Pharmaceutisch Weekblad. 147, 16, 1 p.

Research output: Contribution to journalArticleAcademicpeer-review

Preparation of monoclonal antibodies: Practice across Europe

Crul, M., Franki, A. S. & Simons, K., 13 Sep 2012, In : European Journal of Oncology Pharmacy. 5, 3-4, p. 6-8 3 p.

Research output: Contribution to journalArticleAcademicpeer-review

2010

Potential drug-drug interactions between anti-cancer agents and community pharmacy dispensed drugs

Voll, M. L., Yap, K. D., Terpstra, W. E. & Crul, M., 1 Oct 2010, In : Pharmacy World and Science. 32, 5, p. 575-580 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

2009

Off-labelgebruik rituximab bij de ziekte van Castleman

Al-Rubaiee, N., Terpstra, W. & Crul, M., 18 Sep 2009, In : Pharmaceutisch Weekblad. 144, 38, p. 163-164 2 p.

Research output: Contribution to journalArticleAcademicpeer-review

2008

Anti-interleukine-5 bij hypereosinofiel syndroom: Mepolizumab (Bosatria)

Kromdijk, W., Leeksma, O., Franssen, E. & Crul, M., 31 Oct 2008, In : Pharmaceutisch Weekblad. 143, 44, p. 30-33 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

2006

Clinical and pharmacologic study of the farnesyltransferase inhibitor tipifarnib in cancer patients with normal or mildly or moderately impaired hepatic function

Siegel-Lakhai, W. S., Crul, M., De Porre, P., Zhang, S., Chang, I., Boot, H., Beijnen, J. H. & Schellens, J. H. M., 1 Oct 2006, In : Journal of Clinical Oncology. 24, 28, p. 4558-4564 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Relationship between cisplatin administration and the development of ototoxicity

Rademaker-Lakhai, J. M., Crul, M., Zuur, L., Baas, P., Beijnen, J. H., Simis, Y. J. W., Van Zandwijk, N. & Schellens, J. H. M., 20 Feb 2006, In : Journal of Clinical Oncology. 24, 6, p. 918-924 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

2005

Klinische en preklinische farmacologie van de combinatie cisplatine en gemcitabine

Crul, M., Van Zandwijk, N., Beijnen, J. H. & Schellens, J. H. M., 18 Mar 2005, In : Pharmaceutisch Weekblad. 140, 11, p. 369-371 3 p.

Research output: Contribution to journalArticleAcademicpeer-review

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours

Siegel-Lakhai, W. S., Crul, M., Zhang, S., Sparidans, R. W., Pluim, D., Howes, A., Solanki, B., Beijnen, J. H. & Schellens, J. H. M., 28 Nov 2005, In : British Journal of Cancer. 93, 11, p. 1222-1229 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Phase I clinical and pharmacologic study of a 2-weekly administration of cisplatin and gemcitabine in patients with advanced non-small cell lung cancer

Rademaker-Lakhai, J. M., Crul, M., Pluim, D., Sparidans, R. W., Baas, P., Beijnen, J. H., Van Zandwijk, N. & Schellens, J. H. M., 1 Oct 2005, In : Anti-Cancer Drugs. 16, 9, p. 1029-1036 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

2004

Quantitative analysis of the novel anticancer drug ABT-518, a matrix metalloproteinase inhibitor, plus the screening of six metabolites in human plasma using high-performance liquid chromatography coupled with electrospray tandem mass spectrometry

Stokvis, E., Rosing, H., Crul, M., Rieser, M. J., Heck, A. J. R., Schellens, J. H. M. & Beijnen, J. H., 1 Mar 2004, In : Journal of Mass Spectrometry. 39, 3, p. 277-288 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

2003

CKD-602 Chong Kun Dang

Crul, M., 1 Dec 2003, In : Current Opinion in Investigational Drugs. 4, 12, p. 1455-1459 5 p.

Research output: Contribution to journalReview articleAcademicpeer-review

DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin

Crul, M., Van Waardenburg, R. C. A. M., Bocxe, S., Van Eijndhoven, M. A. J., Pluim, D., Beijnen, J. H. & Schellens, J. H. M., 15 Jan 2003, In : Biochemical Pharmacology. 65, 2, p. 275-282 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer

Crul, M., Schoemaker, N. E., Pluim, D., Maliepaard, M., Underberg, R. W. M., Schot, M., Sparidans, R. W., Baas, P., Beijnen, J. H., Van Zandwijk, N. & Schellens, J. H. M., 1 Oct 2003, In : Clinical Cancer Research. 9, 10 I, p. 3526-3533 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

2002

Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518

Crul, M., Beerepoot, L. V., Stokvis, E., Vermaat, J. S. P., Rosing, H., Beijnen, J. H., Voest, E. E. & Schellens, J. H. M., 19 Dec 2002, In : Cancer Chemotherapy and Pharmacology. 50, 6, p. 473-478 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

DNA-based drug interactions of cisplatin

Crul, M., van Waardenburg, R. C. A. M., Beijnen, J. H. & Schellens, J. H. M., 1 Jan 2002, In : Cancer Treatment Reviews. 28, 6, p. 291-303 13 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Evaluation of the bioequivalence of tablets and capsules containing the novel anticancer agent R115777 (Zarnestra) in patients with advanced solid tumors

Crul, M., De Klerk, G. J., Swart, M., Weiner, L., Palmer, P. A., Bol, C. J., Beijnen, J. H. & Schellens, J. H. M., 1 Jan 2002, In : European Journal of Drug Metabolism and Pharmacokinetics. 27, 1, p. 61-65 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

Isocratic ion-exchange chromatographic assay for the nucleotide gemcitabine triphosphate in human white blood cells

Sparidans, R. W., Crul, M., Schellens, J. H. M. & Beijnen, J. H., 25 Nov 2002, In : Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 780, 2, p. 423-430 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours

Crul, M., Rosing, H., De Klerk, G. J., Dubbelman, R., Traiser, M., Reichert, S., Knebel, N. G., Schellens, J. H. M., Beijnen, J. H. & Ten Bokkel Huinink, W. W., 23 Aug 2002, In : European Journal of Cancer. 38, 12, p. 1615-1621 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Phase I clinical and pharmacologic study of chronic oral administration of the farnesyl protein transferase inhibitor R115777 in advanced cancer

Crul, M., de Klerk, G. J., Swart, M., van't Veer, L. J., de Jong, D., Boerrigter, L., Palmer, P. A., Bol, C. J., Tan, H., de Gast, G. C., Beijnen, J. H. & Schellens, J. H. M., 1 Jun 2002, In : Journal of Clinical Oncology. 20, 11, p. 2726-2735 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Population pharmacokinetics of the novel anticancer agent KRN7000

Crul, M., Mathôt, R. A., Giaccone, G., Punt, C. J., Rosing, H., Hillebrand, M. J., Ando, Y., Nishi, N., Tanaka, H., Schellens, J. H. & Beijnen, J. H., 6 Apr 2002, In : Cancer Chemotherapy and Pharmacology. 49, 4, p. 287-293 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

2001

Een nieuwe klasse oncolytica

Crul, M., Underberg, R. W. M., Beijnen, J. H. & Schellens, J. H. M., 23 Feb 2001, In : Pharmaceutisch Weekblad. 136, 8, p. 260-265 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Ras biochemistry and farnesyl transferase inhibitors: A literature survey

Crul, M., De Klerk, G. J., Beijnen, J. H. & Schellens, J. H. M. S., 17 Apr 2001, In : Anti-Cancer Drugs. 12, 3, p. 163-184 22 p.

Research output: Contribution to journalLiterature reviewAcademicpeer-review

Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry

Crul, M., Van Den Bongard, H. J. G. D., Tibben, M. M., Van Tellingen, O., Sava, G., Schellens, J. H. M. & Beijnen, J. H., 1 Mar 2001, In : Analytical and Bioanalytical Chemistry. 369, 5, p. 442-445 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

1999

Geneesmiddelprofiel: Sulesomab (LeukoScan®)

Crul, M., Franssen, E. J. F. & Wilhelm, A. J., 22 Oct 1999, In : Pharmaceutisch Weekblad. 134, 42, p. 1430-1432 3 p.

Research output: Contribution to journalArticleAcademicpeer-review

1997

Cisplatin resistance and DNA repair

Crul, M., Schellens, J. H. M., Beijnen, J. H. & Maliepaard, M., 1 Jan 1997, In : Cancer Treatment Reviews. 23, 5-6, p. 341-366 26 p.

Research output: Contribution to journalArticleAcademicpeer-review